trending Market Intelligence /marketintelligence/en/news-insights/trending/vjre_hyopij5u6l574xoua2 content esgSubNav
In This List

Canntab Therapeutics director resigns

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Canntab Therapeutics director resigns

Canntab Therapeutics Ltd. said Sheldon Inwentash resigned from its board to pursue other opportunities.

The Canada-based company develops advanced pharmaceutical-grade formulations of cannabinoids.